Intezyne Technologies' Series A Round

Intezyne Technologies raised a round of funding on October 06, 2017. Investors include Gaston Capital Partners.

Intezyne Technologies is dedicated to treating cancer better. Intezyne's nanotechnology platform, the IVECT(TM) Method, can be generated around a broad array of drugs, from small molecules to peptides…

Articles about Intezyne Technologies' Series A Round: